Background. Rewiring cellular metabolism is important for activation of immune cells during host defense against Mycobacterium tuberculosis. Glutamine has been implicated as an immunomodulatory nutrient, but its role in the response to M. tuberculosis is unknown.
Changes in cellular metabolism play a vital role in the initiation and regulation of the immune response. Once infected, immune cells undergo rewiring of cellular metabolism to adapt to the infection and generate sufficient energy to perform host defense functions. Metabolic reprogramming is also important for host responses against Mycobacterium tuberculosis, the causative agent of tuberculosis. M. tuberculosis induces a switch in cellular metabolism in peripheral blood mononuclear cells (PBMCs) toward aerobic glycolysis. This metabolic switch is mediated through the AKT-mTOR pathway, and inhibition of glycolysis results in reduced cytokine production and mycobacterial killing [1, 2] . We have recently identified other metabolic pathways, including glutathione and pyrimidine metabolism, to be differentially expressed at the tissue level in patients with tuberculosis, and to alter T-helper type 1 (Th1) and Th17 production in response to M. tuberculosis [3] . However, the role of other metabolic pathways in the immune response against M. tuberculosis remains largely unknown.
Glucose can be used to generate ATP either through glycolysis, which involves the conversion of glucose to pyruvate and, thereafter, through fermentation, to lactate in the cytoplasm, or by oxidation of pyruvate in the tricarboxylic acid cycle, which generates nicotinamide adenine dinucleotide and flavin adenine dinucleotide to fuel oxidative phosphorylation [4] . Glutamine, a nonessential amino acid, can be used as an additional carbon source to fuel the tricarboxylic acid cycle, by a process called glutaminolysis. To accomplish this, glutamine is converted to glutamate by the enzyme glutaminase, and the enzyme glutamate dehydrogenase mediates the conversion from glutamate to α-ketoglutarate, which is a substrate for the tricarboxylic acid cycle. The importance of glutamine metabolism during activation of the host defense has been described in other infections. For instance, during cytomegalovirus infection, glutamine consumption increases, and infected cells become dependent on glutamine for ATP production [5] . In addition, glutaminolysis is essential for the induction of trained immunity (innate immune memory) in monocytes [6] .
The aim of this study was to examine the relevance of glutamine metabolism in the host responses against M. tuberculosis.
For this purpose, we assessed whether genes involved in glutaminolysis are modulated during M. tuberculosis infection, we studied the effect of blocking glutaminolysis on M. tuberculosis-induced cytokines, and we examined whether variation in glutamine pathway genes acted as quantitative trait loci (QTL) for ex vivo M. tuberculosis-induced cytokines in a cohort of 500 individuals.
METHODS

PBMC Isolation and Stimulation
Informed consent from healthy volunteers was obtained for use of their blood for scientific purposes, as approved by the Ethics Committee of Radboud University Medical Center (Nijmegen, the Netherlands). PBMCs were isolated from buffy coats obtained from healthy volunteers (Sanquin Bloodbank, Nijmegen, the Netherlands). Isolation was performed using Ficoll-Paque, involving separation by a density gradient followed by 3 wash steps in cold phosphate-buffered saline and resuspension in Roswell Park Memorial Institute 1640 (Life Technologies, Paisley, UK) supplemented with 10 μg/mL gentamicin, 2 mM GlutaMAX (except for the glutamine depletion experiment), and 5.5 mmol/L glucose. After isolation, PBMCs (5 × 10 5 cells/well) were seeded in 96-well round-bottomed plates and stimulated with M. tuberculosis H37Rv lysate (1 µg/ mL), Candida albicans (1 × 10 6 copies/mL), Staphylococcus aureus (1 × 10 6 copies/mL), phytohemagglutinin (10 µg/mL), or culture medium. The cultures were incubated for 24 hours or 7 days at 37°C in 5% CO 2 and supplemented with 10% human pooled serum, for cultures stimulated for 7 days, after which supernatants were collected and stored at −20°C. In some experiments, cells were preincubated (before stimulation) for 1 hour with 600 μM gamma-L-glutamyl-p-nitroanilide (GPNA), 10 μM 6-Diazo-5-oxo-L-norleucine (DON), 30 μM C968, 50 μM BPTES (Sigma), or 5 mM aminooxyacetate.
Cytokine and Lactate Measurements
Enzyme-linked immunosorbent assays were performed on supernatants from the PBMC stimulations following the manufacturer's protocols for measuring cytokines in supernatants. The concentrations of interleukin 1β (IL-1β), tumor necrosis factor α (TNF-α; R&D Systems, Minneapolis, MN), IL-10, and IL-6 (Sanquin, Amsterdam, the Netherlands) were measured after incubation for 1 day, and the concentrations of IFN-γ (Sanquin), IL-17 (R&D Systems), and IL-22 (R&D Systems) were measured after 7 days. Lactate concentrations were measured after 1 day of incubation using fluorometric quantification assay kits (Biovision, Milpitas, CA).
Metabolite Measurements
After cell culture, cells were lysed in 0.5% Triton-X in phosphate-buffered saline. Concentrations of fumarate, glutamate, pyruvate, α-ketoglutarate, and malate were determined by commercial kits (Sigma), according to the instructions of the manufacturer.
Cell Death Assay
To measure the effect of the tested inhibitors on cell death, annexin V-FITC conjugate (Biovision) and proprium iodide were added after stimulation. Annexin V stains phosphatidylserine translocating from the inner to the outer leaflet of the membrane, marking early apoptosis. Proprium iodide stains nuclei from cells that are permeable, reflecting cell death, either from advanced apoptosis or necrosis. Flow cytometry using Cytomics FC500 was performed to distinguish annexin V-FITC conjugate-and proprium iodide-negative (alive) populations, annexin V-FITC conjugate-positive and proprium iodide-negative (early apoptotic) populations, and annexin V-FITC conjugate-and proprium iodide-positive (advanced apoptotic/necrotic) populations.
In Vitro Gene Expression Data Set
CD14
+ monocytes were isolated from PBMCs by magnetic cell sorting with anti-CD14-coated MACS microbeads (Miltenyi Biotec) and seeded in tissue culture-treated flasks (Corning). After 6 days of differentiation in the presence of 50 ng/mL macrophage colony-stimulating factor, macrophages were harvested using trypsin and transferred to tissue culture-treated 24-well plates (Corning) with 300 000 macrophages per well. Macrophages were incubated overnight at 37°C in 5% CO 2 and subsequently infected with the H37Rv strain of M. tuberculosis. Bacterial density was determined by measuring the OD 600 , and the bacterial suspension was diluted to a concentration of 30 × 10 6 bacteria/mL to infect the macrophages at a multiplicity of infection of 10. A total of 100 μL of the bacterial suspension was added to the cell cultures, after which the plates were centrifuged for 3 minutes at 600 g and incubated at 37°C in 5% CO 2 . After 60 minutes, the plates were washed with culture medium containing 30 μg/mL gentamicin to kill extracellular bacteria and were subsequently incubated overnight at 37°C in 5% CO 2 in medium containing 5 μg/mL gentamicin. Cells were lysed by direct addition of TRIzol to the wells, followed by RNA extraction. RNAseq libraries were prepared from 1 μg of RNA, using the TruSeq RNA sample preparation kit v2 (Illumina) according to the manufacturer's instructions, and these libraries were subsequently sequenced on a HiSeq 2000 sequencer (Illumina), using single-end sequencing of 50 bp, upon pooling of 10 samples per lane.
In Vivo Gene Expression Data Set
We downloaded previously published whole blood microarray data from patients with pulmonary tuberculosis (culture positive), patients with latent M. tuberculosis infection, and healthy controls (tuberculin skin test and IFN-γ release assay negative) [7] . Each microarray was scaled to the median average intensity for all samples (per-chip normalization). These data were obtained from the Gene Expression Omnibus, under accession number GSE19491.
Cytokine Quantitative Trait Loci (cQTL) Analyses
Single-nucleotide polymorphisms (SNPs) in 16 genes from the glutamine pathway were identified. SNPs were then mapped (P < .05 cutoff) for cQTLs in the 500FG cohort. This cohort consists of 500 healthy individuals of Dutch European ancestry from the Human Functional Genomics Project (available at: http:// www.humanfunctionalgenomics.org), from whom PBMCs or macrophages were obtained and stimulated by heat-killed M. tuberculosis, followed by measurement of IFN-γ, IL-17, and IL-22 (7 days after stimulation) and IL-1β, IL-6, and TNF-α (24 hours after stimulation) secretion, as previously described [8] . To identify cQTLs, raw cytokine levels were first log transformed then mapped to genotype data, using a linear regression model with age and sex as covariates. P values were obtained using linear regression analysis of cytokine on genotype data, as previously described [8] . These cQTL data are publically available at: http:// www.humanfunctionalgenomics.org.
Statistical Analysis
The nonparametric Wilcoxon matched-pairs signed-rank test was used to compare cytokine and metabolite data from the in vitro experiments between groups. P values of ≤.05 were considered statistically significant. These statistical analyses were performed using GraphPad Prism 5.03. To analyze the gene expression data sets, principal component analyses were performed on centered, scaled data, using "prcomp. " The heatmap was generated using "heatmap, " and samples were ordered using hierarchical clustering. All analyses performed on gene expression data were performed using R 3.2.2 (available at: http://www.R-project.org).
RESULTS
Transcriptional Changes in Genes Involved in Glutamine Metabolism In Vivo and in M. tuberculosis-Infected Macrophages
We examined whether M. tuberculosis infection leads to an altered expression of genes of the glutamate pathway, using macrophages infected in vitro and available blood transcriptome data from patients and controls. Based on expression of genes from the glutamine pathway, M. tuberculosis-infected macrophages could be clearly separated from uninfected macrophages, using principal component analysis ( Figure 1A ). To further understand the class separation between infected and uninfected macrophages, samples were clustered by means of an unsupervised hierarchical clustering method, using the gene expression of these glutamine pathway genes. Two major clusters were found, one containing the M. tuberculosis-infected macrophages and one with the uninfected macrophages ( Figure 1B) . Overall, M. tuberculosis infection led to higher expression of genes involved in transport and glutamine use. In addition,
M. tuberculosis infection decreased expression of several genes involved in the tricarboxylic acid cycle, whereas ME2, which converts malate into pyruvate, and GLUD2, which converts glutamine to α-ketoglutarate, were specifically upregulated. Patients with pulmonary tuberculosis and uninfected control subjects were clearly separated, based on expression of these glutamine pathway genes in their whole-blood specimens, while individuals with latent M. tuberculosis infection were spread throughout the plot ( Figure 1C ).
M. tuberculosis-Induced Cytokines Responses Are Decreased After
Glutamine Depletion
To study the effect of M. tuberculosis on glutamine metabolism, we assessed whether M. tuberculosis stimulation increased the production of glutamine-derived metabolites in vitro. PBMCs stimulated with M. tuberculosis showed a significant increase in intracellular glutamate and malate production (P = .019 and .022, respectively, by the Wilcoxon signed-rank test), a strong increase in α-ketoglutarate production, and no difference in fumarate and pyruvate production ( Figure 2A ). Subsequently, we examined the effect of glutamine deprivation on cytokine production in response to M. tuberculosis. Glutamine depletion resulted in a significant decrease in IL-1β, IFN-γ, and IL-17 produced by PBMCs (P = .004, .020, and .037, respectively, by the Wilcoxon signed-rank test; Figure 2B ). To study whether this decrease in cytokine production upon glutamine deprivation was linked to lactate production, lactate levels were measured in supernatants from cultured monocytes and PBMCs. No differences in lactate levels were observed ( Figure 2C ), suggesting that glutamate is not a fuel for lactate production upon stimulation with M. tuberculosis.
Inhibition of Glutamine Transport and Metabolizing Enzymes Decrease Cytokine Production
To determine which steps of glutamine use influence cytokine production by M. tuberculosis-stimulated PBMCs, pharmacologic inhibitors were added during culture. A schematic diagram indicating the site of action of the different inhibitors is depicted in Figure 3 . First, addition of GPNA, a competitive inhibitor of glutamine uptake via the SLC1A5 glutamine transporter, led to a decrease in the production of TNF-α and IL-17. Next, the effects of inhibition of glutaminase, an enzyme responsible for the conversion of glutamine into glutamate, the first step of glutaminolysis, was examined using 3 different compounds: DON, BPTES, and C968. Addition of DON, a broad-spectrum glutaminase inhibitor, significantly decreased the production of IL-17, IFN-γ, and IL-22 during stimulation of PBMCs but did not affect any of the monocyte-derived cytokines. GLUL  GFPT2  GCLM  GCLC  ME3  ME2  ME1  LDHB  LDHA  SUCLG2  SUCLG1  SDHC  SDHB  SDHA  MDH2  MDH1  FH  DLST  DLD  GPT2   GOT1  GLUD2  GLUD1  GLS  SLC7A5  SLC3A2 of these inhibitors on cytokine production are summarized in Figure 4 .
Impact of Genetic Variants on Glutamine-Dependent Cytokine Responses
Last, we examined whether genetic variation in genes involved in the glutamine pathway affects host response to M. tuberculosis.
To do so, we tested whether common genetic variants (minor allele frequency, ≥5%) in glutamine-related genes are associated with differences in cytokine secretion in response to M. tuberculosis stimulation, using a cohort of 500 healthy individuals from the Human Functional Genomics Project (available at: http://www.humanfunctionalgenomics.org). We identified 13 cQTLs in 7 genes related to glutamine metabolism ( Table 1 ). The strongest cQTLs were identified in genes encoding the high-affinity glutamine receptor, SLC1A5, and 2 enzymes involved in the conversion of glutamine to glutamate, GLS and GLUD. Finally, we investigated the known effects of the identified QTLs on gene expression. This was done using the publically available cohort of Westra et al [9] , who performed an expression QTLs meta-analysis in nontransformed peripheral blood samples. Four of our identified cytokine QTLs were also known expression QTLs (Table 1) . This means that these genetic variants regulate both gene expression and cytokine production, suggesting that these genes might mediate the regulation of cytokines. the role of glutamine metabolism in M. tuberculosis infection. Transcriptional changes in glutamine-related genes were evident in vitro in M. tuberculosis-infected macrophages and cells from patients with pulmonary tuberculosis, compared with healthy subjects. Glutamine depletion or glutamine pathway inhibitors predominantly reduced T-helper cell cytokine production. These findings were substantiated by the identification of SNPs in genes of the glutamine pathway that affected cytokine production in response to M. tuberculosis stimulation of human PBMCs. Together, these data underline the importance of glutamine metabolism in tuberculosis.
Interestingly, most glutamine metabolism inhibitors appeared to have a stronger affect on T cell-derived cytokine production (IFN-γ, IL-17, and IL-22) as compared to monocyte-derived cytokine production (TNF-α, IL-6, IL-1β, and IL-10), suggesting a more prominent role for glutamine metabolism in the differentiation of T-helper cells. This is supported by data from Nakaya et al, who showed that stimulation of naive CD4 + T cells triggered glutamine uptake and that glutamine was required for the differentiation of naive T cells to Th1 and Th17 inflammatory T cells [10] . The critical role for T-cell immunity in the control of M. tuberculosis is evident, as defects in Th1 cytokine production, particularly IFN-γ, are risk factors for infection and disease progression [11] . A balance between Th1 and Th17 responses is essential to control bacterial growth and limit immunopathology, as a shift of the response toward excessive IL-17 production may cause extensive neutrophil recruitment and tissue damage [12] . Genes involved in the glutamine pathway were differentially expressed after M. tuberculosis stimulation in vitro. We also observed genetic polymorphisms in glutamine pathway genes, including GLS2, SLC1A5, and SLC7A5, that controlled M. tuberculosis-induced cytokine production, which further strengthens the role of glutamine metabolism in the host defense against M. tuberculosis. This is not the first study that observed immunomodulatory effects of glutamine. In an experimental cerebral malaria study, inhibition of glutamine metabolism improved survival of mice by inhibiting CD8 + T-cell effector functions [13] . In addition, glutaminolysis is essential for the induction of innate immune memory, termed "trained immunity" [6] . In a murine study, a sustained trained immunity response was induced by β-glucan through modulation of hematopoietic stem and progenitor cells, which was associated with adaptations in glucose metabolism and cholesterol biosynthesis [14] . Interestingly, intravenous BCG vaccination also led to changes in hematopoietic stem and progenitor cells, and these epigenetically modified macrophages provide better protection against M. tuberculosis infection [15] . Therefore, targeting the glutamine pathway might be a promising approach to modulate the immune response against M. tuberculosis through modulation of trained immunity. Our study has some limitations. The cytokines studied in our in vitro assays and the cQTL analysis represent only one component of the host immune response against M. tuberculosis infection. The role of glutamine metabolism on other aspects of the immune response, such as mycobacterial killing or phagocytosis, have not been explored in this study. Also, the relevance of glutamine metabolism during in vivo infection is yet to be fully explored. Future studies should investigate the role of glutamine metabolism in live infection models and study its role in susceptibility to tuberculosis in infected patients. In addition, tracer infusion studies could help unravel the in vivo aspects of glutamine metabolism upon infection [16] .
In conclusion, our study has identified glutamine metabolism as a fundamental metabolic process needed to mount an effective host response against M. tuberculosis. Earlier, we have identified other metabolic pathways, including glutathione and pyrimidine metabolism, to be relevant for host responses in tuberculosis [3] . These studies and others underline the relevance of cellular metabolism for the response of immune cells to M. tuberculosis and its potential role in developing new preventive or therapeutic strategies for tuberculosis. Abbreviations: IFN-γ, interferon γ; IL-1 β, interleukin 1 β; IL-6, interleukin 6; IL-17, interleukin 17; IL-22, interleukin 22; SNP; single-nucleotide polymorphism.
